Twenty funding requests yielded 32 grants

Brussels, 29 November 2017: Experts unveiled a set of recommendations on Wednesday to address health problems facing people living with HIV. Treatments are helping people with HIV live long lives, but they face higher risk than others of serious illnesses – from cancer to heart ...

HIV remains one of the continent’s most intractable health challenges. Tremendous progress is being made to understand the virus, the immune mechanisms that contribute to its control and for new antiretroviral drugs and vaccines to be developed to treat and prevent HIV. But much remains to ...

An 8-week course of sofosbuvir/ledipasvir (Harvoni) led to a sustained response in all people with HIV and genotype 1 or 4 hepatitis C virus (HCV) in the SWIFT-C study, according to a report at the AASLD Liver Meeting last month in Washington, DC.

The study shows that clinical interventions should take place at lower viral loads than those proposed by the current World Health Organization guidelines.

This report presents data on HIV and AIDS in 51 of 53 countries in the WHO European Region, and in the European Union and European Economic Area (EU/EEA).

The WHO European Region is the only region worldwide where the number of new HIV infections is rising. With more than 160 000 people newly diagnosed with HIV across the Region, including more than 29 000 new cases from the European Union and European Economic ...

The representatives of the Ministry of Health of Lithuania, the National Medicinal Products Control Service and the Patent Services of Lithuania, as well as representatives of patient organizations from Vilnius, Kaunas, Klaipeda and Ukmerge, attended the event. "ECUO PLWH, representing the patient community of Eastern Europe ...

FDA approved Juluca, the first complete treatment regimen containing only two drugs to treat certain adults with human immunodeficiency virus type 1 (HIV-1).

Petition signed by more than 30,000 people from 120 countries presented to head of WHO and Ministers of Health.

The delegation of the East Europe and Central Asia Union of People Living with HIV (ECUO PLWH) took part in an open regional consultation on a new grant from the Global Fund, which was held in Minsk on November 13-14, 2017. The representatives of key community ...

New report from UNAIDS highlights the right to health as the key to ending AIDS.

The type of vaccine administered and the activation of the body's own immune cells influence the vaccine protection.

A second-line HIV regimen containing the integrase inhibitor raltegravir failed to meet its primary endpoint of noninferiority against standard second-line treatment with nucleoside reverse-transcriptase inhibitors, or NRTIs, according to 144-week data from the EARNEST trial.

The European HIV-Hepatitis Testing Week started today. It will last from November 17 to November 24. The East Europe and Central Asia Union of People Living with HIV (ECUO PLWH) supported the initiative and joined the testing campaign. The slogan of the weekly campaign is "Test. ...

Public Health England (PHE) has published its annual elimination of HIV and HIV testing reports for 2017.

The system of efficient and transparent public procurement is the Republic is not yet established.

The main goal of EECA CAB is to improve access to the treatment of HIV, HCV and TB in the countries of the region